Advisor Net Financial, Inc Invitae Corp Transaction History

Advisor Net Financial, Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	BUY	$0.01 - $0.61 $300 - $18,300	30,000 Added 150.0%	50,000 $0
Q3 2023 Oct 12, 2023	BUY	$0.6 - $1.53 $6,000 - $15,300	10,000 Added 100.0%	20,000 $12,000
Q3 2022 Oct 04, 2022	BUY	$1.9 - $8.63 $7,197 - $32,690	3,788 Added 60.98%	10,000 $25,000
Q2 2022 Jul 07, 2022	BUY	$2.13 - $9.01 $4,711 - $19,930	2,212 Added 55.3%	6,212 $15,000
Q1 2022 Apr 14, 2022	BUY	$6.28 - $15.59 $6,280 - $15,590	1,000 Added 33.33%	4,000 $32,000
Q4 2021 Jan 19, 2022	BUY	$14.7 - $28.67 $14,185 - $27,666	965 Added 47.42%	3,000 $46,000
Q1 2021 Apr 14, 2021	BUY	$33.06 - $56.93 $59,508 - $102,474	1,800 Added 765.96%	2,035 $78,000
Q4 2020 Feb 04, 2021	BUY	$39.09 - $57.4 $1,368 - $2,009	35 Added 17.5%	235 $10,000
Q3 2020 Nov 06, 2020	SELL	$28.43 - $44.67 $3,553 - $5,583	-125 Reduced 38.46%	200 $9,000
Q2 2020 Aug 26, 2020	SELL	$11.71 - $30.29 $2,342 - $6,058	-200 Reduced 38.1%	325 $10,000
Q1 2020 May 14, 2020	BUY	$7.64 - $27.5 $1,528 - $5,500	200 Added 61.54%	525 $7,000
Q4 2019 Feb 12, 2020	BUY	$15.02 - $20.57 $4,881 - $6,685	325 New	325 $5,000
Q1 2018 May 08, 2018	SELL	$4.69 - $10.05 $7,400 - $15,858	-1,578 Closed	0 $0
Q4 2017 Feb 27, 2018	BUY	$7.86 - $9.99 $12,403 - $15,764	1,578	1,578 $14,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

Stay updated on Advisor Net Financial, Inc with notifications on news.